RORs in autoimmune disease

Current Topics in Microbiology and Immunology

Volumn 378, Issue , 2014, Pages 171-182

  Chang, Mi Ra ^a   Rosen, Hugh ^a   Griffin, Patrick R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; PROTEIN NR1F; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR GAMMA; RETINOIC ACID RECEPTOR RELATED ORPHAN RECEPTOR; UNCLASSIFIED DRUG; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CELLULAR IMMUNITY; DISEASE ASSOCIATION; HUMAN; IMMUNOPATHOLOGY; INNATE IMMUNITY; LIGAND BINDING; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; TH17 CELL; ANIMAL; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; REVIEW;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; TH17 CELLS;

EID: 84904247908     PISSN: 0070217X     EISSN: 21969965     Source Type: Book Series    
DOI: 10.1007/978-3-319-05879-5_8     Document Type: Article

References (66)

1. Alonzi T et al (1998) Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187(4):461–468
2. Andre E et al (1998a) Disruption of retinoid-related orphan receptor beta changes circadian behavior, causes retinal degeneration and leads to vacillans phenotype in mice. EMBO J 17(14):3867–3877
3. Andre E, Gawlas K, Becker-Andre M (1998b) A novel isoform of the orphan nuclear receptor RORbeta is specifically expressed in pineal gland and retina. Gene 216(2):277–283
4. Barish GD et al (2005) A nuclear receptor atlas: macrophage activation. Mol Endocrinol 19(10):2466–2477
5. Becker-Andre M, Andre E, DeLamarter JF (1993) Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem Biophys Res Commun 194(3):1371–1379
6. Bertolini DR et al (1986) Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 319(6053):516–518
7. Burris TP (2008) Nuclear hormone receptors for heme: REV-ERB alpha and REV-ERB beta are ligand-regulated components of the mammalian clock. Mol Endocrinol 22(7):1509–1520
8. Chang MR et al (2014) Pharmacological repression of RORgamma is therapeutic in the collageninduced arthritis experimental model. Arthritis Rheumatd 66(3):579–588
9. Carlberg C et al (1994) RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol Endocrinol 8(6):757–770
10. Clinckemalie L et al (2012) The hinge region in androgen receptor control. Mol Cell Endocrinol 358(1):1–8
11. Dayer JM, Beutler B, Cerami A (1985) Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 162(6):2163–2168
12. Duerr RH et al (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314(5804):1461–1463
13. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240(4854):889–895
14. Fossiez F et al (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183(6):2593–2603
15. Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4(3):281–286
16. Gaffen SL (2008) An overview of IL-17 function and signaling. Cytokine 43(3):402–407
17. Genovese MC et al (2010) LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. Arthritis Rheum 62(4):929–939
18. Griffin PR et al (2011) Modulators of the retinoic acid receptor-related orphan receptors. The Scripps Research Institute. WO 2011115892
19. Giguere V et al (1994) Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev 8(5):538–553
20. Gu Y et al (2008) Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 38(7):1807–1813
21. Hamilton BA et al (1996) Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 379(6567):736–739
22. Heery DM et al (1997) A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature 387(6634):733–736
23. Hirose T, Smith RJ, Jetten AM (1994) ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle. Biochem Biophys Res Commun 205(3):1976–1983
24. Hot A, Miossec P (2011) Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann Rheum Dis 70(5):727–732
25. Hu X, Lazar MA (1999) The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors. Nature 402(6757):93–96
26. Ivanov II et al (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126(6):1121–1133
27. Jetten AM (2009) Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl Recept Signal 7:e003
28. Jetten AM, Kurebayashi S, Ueda E (2001) The ROR nuclear orphan receptor subfamily: critical regulators of multiple biological processes. Prog Nucleic Acid Res Mol Biol 69:205–247
29. Joosten LA et al (1999) IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation. J Immunol 163(9):5049–5055
30. Kamenecka TM et al (2013) Synthetic modulators of the retinoic acid receptor-related orphan receptors. Medchemcomm 4(5):764–776
31. Kishimoto T (2005) Interleukin-6: from basic science to medicine–40 years in immunology. Annu Rev Immunol 23:1–21
32. Koenders MI et al (2005) Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1, Am J Pathol 167(1):141–149
33. Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21(4):467–476
34. Korn T et al (2009) IL-17 and Th17, Cells. Annu Rev Immunol 27:485–517
35. Kotake S et al (1999) IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103(9):1345–1352
36. Krasowski MD, Reschly EJ, Ekins S (2008) Intrinsic disorder in nuclear hormone receptors. J Proteome Res 7(10):4359–4372
37. Kumar N et al (2010a) Campaign to identify novel modulators of the retinoic acid receptorrelated orphan receptors (ROR). Probe Reports from the NIH Molecular Libraries Program
38. Kumar N et al (2010) The benzenesulfoamide T0901317 [N-(2, 2, 2-trifluoroethyl)-N-[4-[2, 2, 2- trifluoro-1-hydroxy-1-(trifluoromethyl)ethy l]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist. Mol Pharmacol 77(2):228–236
39. Kumar N et al (2012) Identification of SR2211: a potent synthetic RORgamma-selective modulator. ACS Chem Biol 7(4):672–677
40. Lubberts E, Koenders MI, van den Berg WB (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther 7(1):29–37
41. Miossec P (2007) Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified. Arthritis Rheum 56(7):2111–2115
42. Moore JT, Collins JL, Pearce KH (2006) The nuclear receptor superfamily and drug discovery. Chem Med Chem 1(5):504–523
43. Nair RP et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NFkappaB pathways. Nat Genet 41(2):199–204
44. Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5(12):993–996
45. Park MC et al (2010) Liver X receptor agonist prevents the evolution of collagen-induced arthritis in mice. Rheumatol (Oxford) 49(5):882–890
46. Privalsky ML (2004) The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315–360
47. Raghuram S et al (2007) Identification of heme as the ligand for the orphan nuclear receptors REV-ERB alpha and REV-ERB beta. Nat Struct Mol Biol 14(12):1207–1213
48. Smolen JS et al (1995) Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 38(1):38–43
49. Solt LA et al (2011) Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 472(7344):491–494
50. Solt LA et al (2012) Identification of a selective RORgamma ligand that suppresses T(H)17 cells and stimulates T regulatory cells. ACS Chem Biol 7(9):1515–1519
51. Song C et al (2008) IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol 181(9):6117–6124
52. Spencer TE et al (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389(6647):194–198
53. Stahl EA et al (2010) Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 42(6):508–514
54. Steinmayr M et al (1998) Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc Natl Acad Sci U S A 95(7):3960–3965
55. Sun Z et al (2000) Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 288(5475):2369–2373
56. Takemura S et al (2001) Lymphoid neogenesis in rheumatoid synovitis. J Immunol 167(2): 1072–1080
57. Tesmer LA et al (2008) Th17 cells in human disease. Immunol Rev 223:87–113
58. Toy D et al (2006) Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177(1):36–39
59. Tremblay GB et al (1999) Dominant activity of activation function 1 (AF-1) and differential stoichiometric requirements for AF-1 and -2 in the estrogen receptor alpha-beta heterodimeric complex. Mol Cell Biol 19(3):1919–1927
60. van de Veerdonk FL et al (2011) The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum 63(6):1507–1516
61. van den Berg WB, Miossec P (2009) IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 5(10):549–553
62. Wang Y et al (2010) Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands. J Biol Chem 285(7):5013–5025
63. Warnmark A et al (2003) Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Mol Endocrinol 17(10):1901–1909
64. Yang XO et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28(1):29–39
65. Yu Q et al (2004) IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: impact on thymocyte development. J Exp Med 200(6):797–803
66. Zwart W et al (2010) The hinge region of the human estrogen receptor determines functional synergy between AF-1 and AF-2 in the quantitative response to estradiol and tamoxifen. J Cell Sci 123(Pt 8):1253–1261